Theravance Biopharma, Inc.
TBPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583107
In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Theravance Biopharma, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 114
- −5 vs. Q4 2022
- Shares held
- 60.2M
- −1.91M (−3.1%) vs. Q4 2022
- Total value
- $652.6M
- −$43.5M (−6.2%) vs. Q4 2022
- New holders
- 10
- 37 more added
- Sold out
- 15
- 44 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TBPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 179 | $817.5M |
| Q1 2026 | 173 | $814.2M |
| Q4 2025 | 169 | $927.2M |
| Q3 2025 | 161 | $706.3M |
| Q2 2025 | 135 | $512.2M |
| Q1 2025 | 132 | $400.9M |
| Q4 2024 | 128 | $422.4M |
| Q3 2024 | 119 | $368.9M |
| Q2 2024 | 132 | $399.5M |
| Q1 2024 | 121 | $430.6M |
| Q4 2023 | 118 | $548.7M |
| Q3 2023 | 115 | $438.5M |
| Q2 2023 | 119 | $546.3M |
| Q1 2023 | 114 | $652.6M |
| Q4 2022 | 119 | $696.1M |
| Q3 2022 | 123 | $649.8M |
| Q2 2022 | 113 | $582.0M |
| Q1 2022 | 121 | $602.5M |
| Q4 2021 | 116 | $655.6M |
| Q3 2021 | 119 | $448.8M |
| Q2 2021 | 109 | $883.1M |
| Q1 2021 | 107 | $1.09B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Theravance Biopharma, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 1,014,993 | $11.0M | 0.02% | −557,657−35.5% | Reduced |
| Geode Capital Management, LLC | 1,186,009 | $12.9M | 0.00% | +45,256+4.0% | Added |
| State Street Corp | 1,411,008 | $15.3M | 0.00% | −21,911−1.5% | Reduced |
| Pictet Asset Management SA | 1,454,267 | $15.8M | 0.02% | +961,879+195.3% | Added |
| Newtyn Management, LLC | 1,531,015 | $16.6M | 3.26% | +81,015+5.6% | Added |
| FMR LLC | 1,714,389 | $18.6M | 0.00% | −759,083−30.7% | Reduced |
| Bank of America Corp | 1,775,966 | $19.3M | 0.00% | +898,691+102.4% | Added |
| Park West Asset Management LLC | 1,900,203 | $20.6M | 1.91% | −20,121−1.0% | Reduced |
| Irenic Capital Management LP | 2,764,048 | $30.0M | 12.47% | +1,063,111+62.5% | Added |
| BlackRock Inc. | 5,142,677 | $55.8M | 0.00% | −188,100−3.5% | Reduced |
| Vanguard Group Inc | 5,626,726 | $61.0M | 0.00% | +67,887+1.2% | Added |
| Madison Avenue Partners, LP | 7,012,226 | $76.1M | 16.36% | 00.0% | Unchanged |
| Weiss Asset Management LP | 7,457,060 | $80.9M | 6.35% | 00.0% | Unchanged |
| Baupost Group LLCSuperinvestorBaupost Group | 10,419,226 | $113.0M | 1.93% | −1,000,000−8.8% | Reduced |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −176,426−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −158,470−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −151,440−100.0% | Sold out |
| Saturn V Capital Management LLC | 0 | $0 | 0.00% | −141,339−100.0% | Sold out |
| Putnam Investments LLC | 0 | $0 | 0.00% | −102,102−100.0% | Sold out |
| Palliser Capital (UK) Ltd | 0 | $0 | 0.00% | −97,100−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −82,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −49,800−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −43,321−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −29,160−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −18,705−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −13,700−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −11,261−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −3,649−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −132−100.0% | Sold out |